Transcatheter Aortic Valve Replacement Market

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

Transcatheter Aortic Valve Replacement Market contains market size and forecasts of Transcatheter Aortic Valve Replacement (TAVR) in Global, including the following market information:

Global Transcatheter Aortic Valve Replacement (TAVR) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Transcatheter Aortic Valve Replacement (TAVR) market was valued at 4124.7 million in 2021 and is projected to reach US$ 11700 million by 2028, at a CAGR of 16.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Transfemoral Approach Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transcatheter Aortic Valve Replacement (TAVR) include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology and Suzhou Jiecheng Medical Technology Co. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transcatheter Aortic Valve Replacement (TAVR) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transcatheter Aortic Valve Replacement (TAVR) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Transcatheter Aortic Valve Replacement (TAVR) Market Segment Percentages, by Type, 2021 (%)

Transfemoral Approach

Transapical Approach

Others

Global Transcatheter Aortic Valve Replacement (TAVR) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Transcatheter Aortic Valve Replacement (TAVR) Market Segment Percentages, by Application, 2021 (%)

Aortic Stenosis

Aortic Regurgitation

Others

Global Transcatheter Aortic Valve Replacement (TAVR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Transcatheter Aortic Valve Replacement (TAVR) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transcatheter Aortic Valve Replacement (TAVR) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Transcatheter Aortic Valve Replacement (TAVR) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Edwards Lifesciences

Medtronic

Abbott

Boston Scientific

Meril Life Sciences

Venus Medtech

Bracco (HLT)

JenaValve Technology

Suzhou Jiecheng Medical Technology Co.

Peijia Medical